These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 30333477

  • 1. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
    Tanabe S, Fujita Y, Ikuma K, Yamashita T.
    Cell Death Dis; 2018 Oct 17; 9(11):1061. PubMed ID: 30333477
    [Abstract] [Full Text] [Related]

  • 2. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, Mun Aui P, Siatskas C, Litwak S, Fehlings MG, Strittmatter SM, Bernard CC.
    Brain; 2012 Jun 17; 135(Pt 6):1794-818. PubMed ID: 22544872
    [Abstract] [Full Text] [Related]

  • 3. Repulsive guidance molecule-a is involved in Th17-cell-induced neurodegeneration in autoimmune encephalomyelitis.
    Tanabe S, Yamashita T.
    Cell Rep; 2014 Nov 20; 9(4):1459-70. PubMed ID: 25456136
    [Abstract] [Full Text] [Related]

  • 4. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.
    Muramatsu R, Kubo T, Mori M, Nakamura Y, Fujita Y, Akutsu T, Okuno T, Taniguchi J, Kumanogoh A, Yoshida M, Mochizuki H, Kuwabara S, Yamashita T.
    Nat Med; 2011 Apr 20; 17(4):488-94. PubMed ID: 21423182
    [Abstract] [Full Text] [Related]

  • 5. Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
    Kubo T, Tokita S, Yamashita T.
    J Neuroimmune Pharmacol; 2012 Sep 20; 7(3):524-8. PubMed ID: 22183806
    [Abstract] [Full Text] [Related]

  • 6. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 20; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 7. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
    Vergo S, Craner MJ, Etzensperger R, Attfield K, Friese MA, Newcombe J, Esiri M, Fugger L.
    Brain; 2011 Feb 20; 134(Pt 2):571-84. PubMed ID: 21233144
    [Abstract] [Full Text] [Related]

  • 8. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.
    Huang L, Fung E, Bose S, Popp A, Böser P, Memmott J, Kutskova YA, Miller R, Tarcsa E, Klein C, Veldman GM, Mueller BK, Cui YF.
    Neurobiol Dis; 2021 Nov 20; 159():105492. PubMed ID: 34478849
    [Abstract] [Full Text] [Related]

  • 9. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T, Tacke S, Schropp V, Zetterberg H, Blennow K, Urich E, Kuerten S.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32962135
    [Abstract] [Full Text] [Related]

  • 10. Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
    Turner MJ, Pang PT, Chretien N, Havari E, LaMorte MJ, Oliver J, Pande N, Masterjohn E, Carter K, Reczek D, Brondyk W, Roberts BL, Kaplan JM, Siders WM.
    J Neuroimmunol; 2015 Aug 15; 285():4-12. PubMed ID: 26198912
    [Abstract] [Full Text] [Related]

  • 11. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
    Madsen PM, Pinto M, Patel S, McCarthy S, Gao H, Taherian M, Karmally S, Pereira CV, Dvoriantchikova G, Ivanov D, Tanaka KF, Moraes CT, Brambilla R.
    J Neurosci; 2017 Oct 18; 37(42):10185-10199. PubMed ID: 28931570
    [Abstract] [Full Text] [Related]

  • 12. Anti-repulsive guidance molecule-a antibody treatment and repetitive transcranial magnetic stimulation have synergistic effects on motor recovery after spinal cord injury.
    Nakanishi T, Fujita Y, Tanaka T, Yamashita T.
    Neurosci Lett; 2019 Sep 14; 709():134329. PubMed ID: 31200090
    [Abstract] [Full Text] [Related]

  • 13. Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice.
    Hirata T, Itokazu T, Sasaki A, Sugihara F, Yamashita T.
    Front Immunol; 2022 Sep 14; 13():870126. PubMed ID: 35784362
    [Abstract] [Full Text] [Related]

  • 14. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Sep 14; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 15. TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system.
    Bittner S, Meuth SG, Göbel K, Melzer N, Herrmann AM, Simon OJ, Weishaupt A, Budde T, Bayliss DA, Bendszus M, Wiendl H.
    Brain; 2009 Sep 14; 132(Pt 9):2501-16. PubMed ID: 19570851
    [Abstract] [Full Text] [Related]

  • 16. Microglia suppress the secondary progression of autoimmune encephalomyelitis.
    Tanabe S, Saitoh S, Miyajima H, Itokazu T, Yamashita T.
    Glia; 2019 Sep 14; 67(9):1694-1704. PubMed ID: 31106910
    [Abstract] [Full Text] [Related]

  • 17. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD.
    J Neuropathol Exp Neurol; 2002 Jan 14; 61(1):23-32. PubMed ID: 11829341
    [Abstract] [Full Text] [Related]

  • 18. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID.
    J Neuropathol Exp Neurol; 2009 Jun 14; 68(6):616-25. PubMed ID: 19458548
    [Abstract] [Full Text] [Related]

  • 19. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS.
    Curr Neurovasc Res; 2005 Oct 14; 2(4):349-62. PubMed ID: 16181126
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.
    Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I.
    Am J Pathol; 2013 Nov 14; 183(5):1390-1396. PubMed ID: 24091251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.